Lymphangiosarcoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Lymphangiosarcoma

MalaCards integrated aliases for Lymphangiosarcoma:

Name: Lymphangiosarcoma ¹¹ ⁴³ ¹⁴ ¹⁶ ⁷¹ ⁷⁵

Stewart Treves Syndrome ¹⁹ ⁴³

Skin Lymphangiosarcoma ¹¹ ⁷¹

Lymphangiosarcoma of Stewart and Treves ¹¹

Malignant Lymphangioendothelioma ¹¹

Stewart-Treves Syndrome ¹¹

Classifications:

MalaCards categories:
Global: Rare diseases Cancer diseases
Anatomical: Immune diseases Skin diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹¹ DOID:2689

MeSH ⁴³ C537491 D008204

NCIt ⁴⁹ C3205 C4490

SNOMED-CT ⁶⁸ 403986008 62497000

EFO ¹⁶ EFO_1000339

UMLS ⁷¹ C0024224 C0346082

Sources

Summaries for Lymphangiosarcoma

Disease Ontology: ¹¹ A lymphatic system cancer that has material basis in endothelial cells located in lymphatic vessels.

MalaCards based summary: Lymphangiosarcoma, also known as stewart treves syndrome, is related to hereditary lymphedema i and conventional angiosarcoma. An important gene associated with Lymphangiosarcoma is TNF (Tumor Necrosis Factor), and among its related pathways/superpathways are Burn wound healing and Angiogenesis (CST). The drugs Coenzyme M and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include lymphatic vessels, endothelial and skin, and related phenotypes are homeostasis/metabolism and muscle

Wikipedia: ⁷⁵ Lymphangiosarcoma is a rare cancer which occurs in long-standing cases of primary or secondary... more...

Sources

Related Diseases for Lymphangiosarcoma

Diseases related to Lymphangiosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 253)

#	Related Disease	Score	Top Affiliating Genes
1	hereditary lymphedema i	30.8	PROX1 PDPN LYVE1 FLT4
2	conventional angiosarcoma	30.6	PECAM1 CD34
3	histiocytoid hemangioma	30.5	PECAM1 CD34
4	primary lymphedema	30.2	TIE1 FLT4
5	congenital lymphedema	30.2	PDPN FLT4
6	sickle cell anemia	30.2	VWF TNF CD34
7	hemangioendothelioma	30.0	FLT4 CD34
8	hemangiopericytoma, malignant	30.0	PECAM1 CD34
9	breast angiosarcoma	29.9	TIE1 PECAM1 FLT4 CD34
10	epithelioid hemangioendothelioma	29.8	PECAM1 FLT4 CD34
11	cavernous hemangioma	29.7	VWF VEGFA PECAM1 CD34
12	lymphangitis	29.7	PDPN LYVE1 FLT4
13	hereditary lymphedema	29.7	PROX1 PDPN LYVE1 FLT4
14	keratitis, hereditary	29.5	VEGFA TNF PECAM1 LYVE1
15	cystic lymphangioma	29.2	PROX1 PECAM1 PDPN FLT4 CD34
16	deficiency anemia	29.2	VWF VEGFA TNF CD34
17	angiosarcoma	29.1	VWF VEGFA TIE1 PECAM1 PDPN FLT4
18	kaposi sarcoma	29.1	VEGFA PECAM1 PDPN LYVE1 FLT4 CD34
19	vascular cancer	28.8	VWF VEGFA PTPRB PECAM1 FLT4 CD34
20	lymphangioma	28.7	VEGFA TNF PROX1 PECAM1 PDPN LYVE1
21	capillary lymphangioma	28.6	VWF PROX1 PECAM1 PDPN LYVE1 FLT4
22	hemangioma	27.9	VWF VEGFA TIE1 PROX1 PECAM1 PDPN
23	skin angiosarcoma	11.0
24	factor viii deficiency	10.4
25	cervical cancer	10.3
26	erysipelas	10.3
27	filarial elephantiasis	10.3
28	angiokeratoma of fordyce	10.3	PROX1 PECAM1
29	skin epithelioid hemangioma	10.3	PECAM1 CD34
30	aorta angiosarcoma	10.2	PECAM1 CD34
31	central nervous system angiosarcoma	10.2	PECAM1 CD34
32	intravascular angioleiomyoma	10.2	PECAM1 CD34
33	malignant ciliary body melanoma	10.2	PROX1 LYVE1
34	ciliary body cancer	10.2	PROX1 LYVE1
35	heart fibrosarcoma	10.2	PECAM1 CD34
36	thyroid angiosarcoma	10.2	PECAM1 CD34
37	glomangioma	10.2	PECAM1 CD34
38	glomangiomatosis	10.2	PECAM1 CD34
39	gallbladder leiomyosarcoma	10.2	PECAM1 CD34
40	venous hemangioma	10.2	PECAM1 CD34
41	kidney hemangiopericytoma	10.2	PECAM1 CD34
42	glomangiomyoma	10.2	PECAM1 CD34
43	angiomyoma	10.2	PECAM1 CD34
44	glomangiosarcoma	10.2	PECAM1 CD34
45	breast hemangioma	10.2	PECAM1 CD34
46	thyroid sarcoma	10.2	PECAM1 CD34
47	liposarcoma of bone	10.2	PECAM1 CD34
48	hemangioma of spleen	10.2	PECAM1 CD34
49	meninges hemangiopericytoma	10.2	PECAM1 CD34
50	cutaneous leiomyosarcoma	10.2	PECAM1 CD34

Graphical network of the top 20 diseases related to Lymphangiosarcoma:

Sources

Symptoms & Phenotypes for Lymphangiosarcoma

MGI Mouse Phenotypes related to Lymphangiosarcoma:

⁴⁵

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	homeostasis/metabolism	MP:0005376	10.1	CD34 FLT4 PDPN PECAM1 PROX1 PTPRB
2	muscle	MP:0005369	10.03	FLT4 PDPN PECAM1 PROX1 PTPRB TIE1
3	digestive/alimentary	MP:0005381	9.97	FLT4 PDPN PECAM1 PROX1 TIE1 TNF
4	cardiovascular system	MP:0005385	9.96	FLT4 LYVE1 PDPN PECAM1 PROX1 PTPRB
5	cellular	MP:0005384	9.92	CD34 LYVE1 PECAM1 PROX1 PTPRB TNF
6	immune system	MP:0005387	9.85	CD34 FLT4 LYVE1 PDPN PECAM1 PROX1
7	respiratory system	MP:0005388	9.43	PDPN PECAM1 PROX1 TIE1 TNF VEGFA
8	integument	MP:0010771	9.17	CD34 FLT4 PDPN PTPRB TIE1 TNF

Sources

Drugs & Therapeutics for Lymphangiosarcoma

Drugs for Lymphangiosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Coenzyme M

Approved, Investigational

Phase 2

3375-50-6

598 23662354

2

Ifosfamide

Approved

Phase 2

3778-73-2

3690

3

Doxorubicin

Approved, Investigational

Phase 2

23214-92-8

31703

Synonyms:

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside

(8S-cis)-10-((3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

(8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

(8S-cis)-10-((3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

14-Hydroxydaunomycin

14-Hydroxydaunorubicine

ADM

ADR

Adriablastin

Adriablastine

Adriamycin

Adriamycin PFS

Adriamycin RDF

Adriamycin Semiquinone

Adriamycin®|Caelyx® (liposomal doxorubicin)|Doxil®|doxorubicin hydrochloride

Adriblastin

Adriblastina

Adriblastine

Adrimedac

Baxter brand OF doxorubicin hydrochloride

Bedford brand OF doxorubicin hydrochloride

Bristol-myers squibb brand OF doxorubicin hydrochloride

Caelyx

Cell pharm brand OF doxorubicin hydrochloride

Columbia brand OF doxorubicin hydrochloride

DM2

DOXIL

Doxo

Doxo cell

Doxo-cell

Doxolem

DOXORUBICIN

Doxorubicin HCl

Doxorubicin hexal

Doxorubicin hydrochloride

Doxorubicin NC

Doxorubicina

Doxorubicina [INN-Spanish]

Doxorubicina ferrer farm

Doxorubicina funk

Doxorubicina tedec

Doxorubicine

Doxorubicine [INN-French]

Doxorubicine baxter

Doxorubicinum

Doxorubicinum [INN-Latin]

Doxotec

Elan brand OF doxorubicin hydrochloride

Farmiblastina

Ferrer brand OF doxorubicin hydrochloride

Hexal brand OF doxorubicin hydrochloride

Hydrochloride, doxorubicin

HYDROXYDAUNORUBICIN

Kenfarma brand OF doxorubicin hydrochloride

Lemery brand OF doxorubicin hydrochloride

Medac brand OF doxorubicin hydrochloride

Myocet

Neocorp brand OF doxorubicin hydrochloride

NSC-123127

Onkodox

Onkoworks brand OF doxorubicin hydrochloride

Pfizer brand OF doxorubicin hydrochloride

Prasfarma brand OF doxorubicin hydrochloride

RDF Rubex

Resmycin

Ribodoxo

Ribosepharm brand OF doxorubicin hydrochloride

Rubex

Tedec meiji brand OF doxorubicin hydrochloride

Urokit doxo cell

Urokit doxo-cell

VALRUBICIN IMPURITY, DOXORUBICIN

4

Palifosfamide

Investigational

Phase 2

31645-39-3

100427

5

Liposomal doxorubicin

Phase 2

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Hypofractionated 5x5 Gy Radiotherapy With Sequential Doxorubicin and Ifosfamide-based Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall	Unknown status	NCT03651375	Phase 2	Sequential chemotherapy - 3 courses of AI

Search NIH Clinical Center for Lymphangiosarcoma

Cochrane evidence based reviews: lymphangiosarcoma

Sources

Genetic Tests for Lymphangiosarcoma

Sources

Anatomical Context for Lymphangiosarcoma

Organs/tissues related to Lymphangiosarcoma:

FMA: Lymphatic Vessels

MalaCards : Endothelial, Skin, Breast, Bone Marrow, Lymph Node, Spinal Cord, Bone

Sources

Publications for Lymphangiosarcoma

Articles related to Lymphangiosarcoma:

(show top 50) (show all 488)

#	Title	Authors	PMID	Year
1	Dusky patches in chronic leg lymphedema - An uncommon presentation of Stewart-Treves syndrome. ⁶²	Gan TS...Baharom ZF	35775097	2022
2	Case for diagnosis. Stewart-Treves syndrome after mastectomy. ⁶²	Sato RAO...Ferreira JASLB	35811194	2022
3	Prospective evaluation of lymphatic embolization as part of the treatment in dogs with presumptive idiopathic chylothorax. ⁶²	Carvajal JL...Toskich BB	35692101	2022
4	A rare and highly malignant Stwart-Treves syndrome case after breast cancer surgery: a case report. ⁶²	Lu H...Yuan R	35935569	2022
5	Unusual coexistence of Stewart-Treves syndrome and sickle cell anaemia: a case of dual pathology. ⁶²	Walke VA...Chaurasia JK	35793854	2022
6	Chronic lymphoedema: a nidus for squamous cell carcinoma. ⁶²	Gulati S...Kose SI	35537771	2022
7	Remarkable response to radiation therapy with concurrent chemotherapy in Stewart-Treves syndrome. ⁶²	Katano A...Yamashita H	35900571	2022
8	Stewart-Treves Syndrome in the Lower Limb after Arthroplasty- A Case Report. ⁶²	Agrawal I...Agrawal I	35287427	2022
9	Stewart-Treves syndrome in an older woman successfully treated by metronomic chemotherapy: case report and literature survey. ⁶²	Marechal S...Focan C	34845161	2022
10	Stewart-Treves syndrome and other cutaneous malignancies in the context of chronic lymphedema: a systematic review. ⁶²	Kim PJ...Yeung J	34196958	2022
11	Rare Case of Cystic Lymphangioma Transforming Into Lymphangiosarcoma: A Case Report. ⁶²	Yu H...Xu X	35251984	2022
12	A case of Stewart-Treves Syndrome in a prostatectomized patient. ⁶²	DE Piano E...Rubegni P	33890737	2021
13	Stewart-Treves Syndrome: A Rare But Aggressive Complication of Breast Cancer-Related Lymphedema. ⁶²	Borman P...Gokoz O	34651118	2021
14	Stewart-Treves Syndrome in Obesity-Associated Chronic Lymphedema: A Case Report. ⁶²	Chaney MJ...Zahra F	34691335	2021
15	Stewart-Treves syndrome associated with disuse edema in amyotrophic lateral sclerosis. ⁶²	Mori T...Kadono T	34058020	2021
16	Stewart-Treves Syndrome. ⁶²	Bernia E...Requena C	33909015	2021
17	Stewart-Treves Syndrome as a Rare and Fatal Complication of Post-Traumatic Lymphedema on the Lower Extremity. ⁶²	Leite LL...Rossato V	33747618	2021
18	Stewart-Treves syndrome: a diagnosis to keep in mind. ⁶²	Gil F...Andrade I	33865293	2021
19	Case Report: Cutaneous Pleomorphic Lymphangiosarcoma in a Dog Exhibiting Features of Human Composite Hemangioendothelioma. ⁶²	Cook MR...Kisseberth WC	34746271	2021
20	[Stewart-Treves syndrome]. ⁶²	Sami G...Chiheb S	34160946	2021
21	Shoulder arthroplasty in patients with upper extremity lymphedema may result in transient or permanent lymphedema worsening. ⁶²	Lee J...Sanchez-Sotelo J	33343716	2020
22	Stewart-Treves syndrome: Case report and literature review. ⁶²	Vojtisek R...Finek J	33088229	2020
23	A case of Stewart-Treves syndrome occurring in the abdominal wall successfully treated with eribulin: A case report. ⁶²	Imura Y...Takenaka S	32874579	2020
24	Stewart-Treves syndrome: a rapidly fatal complication of breast cancer treatment. ⁶²	Hsu A...Dizon DS	33002445	2020
25	Scalp lymphangiosarcoma: A distinct skin manifestation of edematous erythema on face and scalp without subcutaneous hemorrhage or preceding condition of lymphedema. ⁶²	Suzuki H...Aiba S	32677036	2020
26	Primary Lymphangiosarcoma of the Urinary Bladder in a Dog. ⁶²	Michishita M...Azakami D	32958144	2020
27	Adipose-derived stem cell therapy shows promising results for secondary lymphedema. ⁶²	Hu LR...Pan J	32843917	2020
28	Targeted therapy for mTORC1-driven tumours through HDAC inhibition by exploiting innate vulnerability of mTORC1 hyper-activation. ⁶²	Yang F...Guan JL	32336756	2020
29	Pathologic and flow cytometric features of a case of canine ventral cervical lymphangiosarcoma. ⁶²	Azevedo CN...Russell KE	32306890	2020
30	Effectiveness of pazopanib for local and lung metastases in Stewart-Treves syndrome. ⁶²	Hayashi M...Shimizu T	32250262	2020
31	IL-23 Expression in Stewart-Treves Syndrome: Two Case Reports and Immunohistochemical Investigation. ⁶²	Yoshida S...Aiba S	32508617	2020
32	Secondary angiosarcoma: A fatal complication of chronic lymphedema. ⁶²	Farzaliyev F...Podleska LE	31236970	2020
33	A case of Stewart-Treves Syndrome of the lower limbs: The usefulness of dermoscopy. ⁶²	Marasca C...Megna M	31407462	2019
34	Prevention of tumor progression in Stewart-Treves syndrome with a low dose of pazopanib. ⁶²	Yamada M...Manabe M	30802322	2019
35	Secondary breast angiosarcoma: A multicentre retrospective survey by the national Italian association of Breast Surgeons (ANISC). ⁶²	Taffurelli M...Galimberti V	30877870	2019
36	Unsuspected Stewart-Treves syndrome clinically mimicked by apparent bullous erysipelas and a systematic review of dermatological presentations of the classical Stewart-Treves syndrome. ⁶²	da Costa Vieira RA...da Silva SRM	32721135	2019
37	Primary Lymphedema of the Upper Extremities: Clinical and Lymphoscintigraphic Features in 23 Patients. ⁶²	Goss JA...Greene AK	30280960	2019
38	Clinicopathologic features of Stewart-Treves syndrome. ⁶²	Wang LL...Jiang ZC	31933875	2019
39	Kaposi Sarcoma and Cutaneous Angiosarcoma: Guidelines for Diagnosis and Treatment. ⁶²	Requena C...Llombart B	30262126	2018
40	Cutaneous Angiosarcoma Postmastectomy (Stewart-Treves Syndrome). ⁶²	Degrieck B...Crevits I	30320298	2018
41	Cutaneous angiosarcoma of the lower leg. ⁶²	Scholtz J...Simman R	30489569	2018
42	Guillain-Barré syndrome in a cancer patient treated with bevacizumab. ⁶²	Taguchi D...Shibata H	31149522	2018
43	Metastatic Angiosarcoma of Lower Extremity. ⁶²	Tambe SA...Nayak CS	29854638	2018
44	[Angiosarcoma in primary lymphoedema: A rare complication]. ⁶²	Farhat MM...Modiano P	29530502	2018
45	Pretibial Located Stewart-Treves Syndrome: Uncommon Presentation in a Bulgarian Patient! ⁶²	Tchernev G...Tronnier M	29731936	2018
46	Successful management of lymphangiosarcoma in a puppy using a tyrosine kinase inhibitor. ⁶²	Kim JH...Kim JH	29606721	2018
47	Stewart-Treves syndrome: Magnetic resonance imaging data compared with pathological results from a single center. ⁶²	Li B...Wang Z	29391898	2018
48	Angiosarcoma complicating lower leg elephantiasis in a male patient: An unusual clinical complication, case report and literature review. ⁶²	Shavit E...Sibbald RG	30397474	2018
49	A Supernumerary Nipple-Like Clinical Presentation of Lymphangioma Circumscriptum. ⁶²	Taylor D...Silapunt S	29796322	2018
50	Morphofunctional basis of the different types of angiogenesis and formation of postnatal angiogenesis-related secondary structures. ⁶²	Diaz-Flores L...Madrid JF	28762232	2017

Sources

Genes for Lymphangiosarcoma

Genes related to Lymphangiosarcoma (0 elite genes):

(show all 11)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	TNF	Tumor Necrosis Factor	Protein Coding	10.31	DISEASES inferred ¹⁴ GeneCards inferred via : Publications (show sections)
2	PECAM1	Platelet And Endothelial Cell Adhesion Molecule 1	Protein Coding	6.94	DISEASES inferred ¹⁴
3	PROX1	Prospero Homeobox 1	Protein Coding	6.69	DISEASES inferred ¹⁴
4	LYVE1	Lymphatic Vessel Endothelial Hyaluronan Receptor 1	Protein Coding	6.34	DISEASES inferred ¹⁴
5	CD34	CD34 Molecule	Protein Coding	6.3	DISEASES inferred ¹⁴
6	FLT4	Fms Related Receptor Tyrosine Kinase 4	Protein Coding	6.08	DISEASES inferred ¹⁴
7	PDPN	Podoplanin	Protein Coding	5.59	DISEASES inferred ¹⁴
8	VWF	Von Willebrand Factor	Protein Coding	5.34	DISEASES inferred ¹⁴
9	VEGFA	Vascular Endothelial Growth Factor A	Protein Coding	5.22	DISEASES inferred ¹⁴
10	PTPRB	Protein Tyrosine Phosphatase Receptor Type B	Protein Coding	5.08	DISEASES inferred ¹⁴
11	TIE1	Tyrosine Kinase With Immunoglobulin Like And EGF Like Domains 1	Protein Coding	4.98	DISEASES inferred ¹⁴

Sources

Variations for Lymphangiosarcoma

Sources

Expression for Lymphangiosarcoma

Search GEO for disease gene expression data for Lymphangiosarcoma.

Sources

Pathways for Lymphangiosarcoma

Pathways related to Lymphangiosarcoma according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Burn wound healing ⁷⁴	11.01	VEGFA TNF PECAM1
2	Angiogenesis (CST) ³	10.97	VWF PROX1 PECAM1 PDPN FLT4
3	Aryl hydrocarbon receptor pathway ⁷⁴	10.85	VEGFA TNF
4	Prostaglandin signaling ⁷⁴	10.77	VEGFA TNF
5	Immune infiltration in pancreatic cancer ⁷⁴	10.69	VEGFA TNF
6	VEGF ligand-receptor interactions ⁶⁶ Show member pathways VEGF binds to VEGFR leading to receptor dimerization ⁶⁶	10.36	VEGFA FLT4

Sources

GO Terms for Lymphangiosarcoma

Cellular components related to Lymphangiosarcoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	plasma membrane	GO:0005886	9.7	TNF TIE1 PTPRB PECAM1 PDPN LYVE1
2	plasma membrane	GO:0005887	9.7	TNF TIE1 PTPRB PECAM1 PDPN LYVE1

Biological processes related to Lymphangiosarcoma according to GeneCards Suite gene sharing:

(show all 15)

#	Name	GO ID	Score	Top Affiliating Genes
1	angiogenesis	GO:0001525	10.1	VEGFA TIE1 PTPRB FLT4
2	positive regulation of cell migration	GO:0030335	10.06	VEGFA PECAM1 PDPN FLT4
3	lung development	GO:0030324	10	VEGFA PROX1 PDPN
4	positive regulation of protein phosphorylation	GO:0001934	9.97	VEGFA TNF PECAM1 FLT4
5	positive regulation of endothelial cell proliferation	GO:0001938	9.91	FLT4 PROX1 VEGFA
6	vascular endothelial growth factor signaling pathway	GO:0038084	9.84	VEGFA FLT4
7	positive regulation of endothelial cell migration	GO:0010595	9.8	VEGFA PROX1 FLT4
8	positive regulation of protein kinase C signaling	GO:0090037	9.78	VEGFA FLT4
9	positive regulation of DNA biosynthetic process	GO:2000573	9.72	VEGFA TNF
10	vascular wound healing	GO:0061042	9.71	VEGFA CD34
11	lymph vessel development	GO:0001945	9.69	PROX1 FLT4
12	lymphatic endothelial cell differentiation	GO:0060836	9.56	TIE1 PROX1
13	glomerular endothelium development	GO:0072011	9.46	PECAM1 CD34
14	lymphatic endothelial cell fate commitment	GO:0060838	9.26	PROX1 PDPN
15	lymphangiogenesis	GO:0001946	9.1	PROX1 PDPN FLT4

Sources

Sources for Lymphangiosarcoma

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: LYM008 MIFTS: 41	Lymphangiosarcoma Categories: Cancer diseases, Immune diseases, Rare diseases, Skin diseases	Data Licensing For inquiries, contact: [email protected]
Genes Tissues Related diseases Publications Drugs Expand all tables